Abstract
Gene therapy has been applied to murine models of rheumatoid arthritis (RA) using a number of different strategies to downregulate inflammation in synovial joints. However, prolonged joint expression has been problematic. Our laboratory has found that early gestational intravascular injection of lentiviral vector leads to efficient transduction and sustained transgene expression in articular cartilage and synovium. In this study, we show that in utero gene transfer of IL-10 can prevent and decrease pathology in a murine model of RA. Following prenatal injection of lentiviral vector containing murine IL-10 gene, the cytokine was detectable in the serum, and the green fluorescent protein reporter gene was detectable in chondrocytes and synoviocytes of adult mice up to 21 weeks of age. Adult mice that had been treated prenatally were later immunized against type II collagen to induce an autoimmune arthritis. Compared with controls, prenatally treated mice demonstrated delayed onset of arthritis, decreased frequency of arthritis and markedly decreased severity of disease, by both clinical and histological criteria. This effect was directly related to levels of IL-10 expression, but no immunosuppressive effects of the therapy were observed. This study demonstrates proof of principle for the prenatal prevention and amelioration of RA by early gestational gene transfer of the anti-inflammatory cytokine, IL-10.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Smolen JS, Hayer S, Schett G, Redlich K, Aringer M, Kollias G et al. Autoimmunity and rheumatoid arthritis. Autoimmun Rev 2004; 3 (Suppl 1): S23.
Tedesco A, D’Agostino D, Soriente I, Amato P, Piccoli R, Sabatini P . A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach. Autoimmun Rev 2009; 8: 233–237.
Courtenay JS, Dallman MJ, Davan AD, Martin A, Mosedale B . Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980; 83: 666–668.
Joe B, Griffiths MM, Remmers EF, Wilder RL . Animal models of rheumatoid arthritis and related inflammation. Curr Rheumatol Rep 1999; 1: 139–148.
Ko HJ, Cho ML, Lee SY, Oh HJ, Heo YJ, Moon YM . CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population. J Autoimmun 2010; 34: 111–120.
Jaen O, Rulle S, Bessis N, Zago A, Boissier MC, Falgarone G . Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo. Immunology 2009; 126: 35–44.
van de Loo FA, van de Berg WB . Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. Rheum Dis Clin North Am 2002; 28: 127–149.
Woods JM, Sitabkhan Y, Koch AE . Gene therapy for rheumatoid arthritis: recent advances. Curr Gene Ther 2008; 8: 24–41.
Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Godlman M et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997; 40: 249–260.
Schulze-Tanzil G, Zreiqat H, Sabat R, Kohl B, Halder A, Müller RD et al. Interleukin-10 and articular cartilage: experimental therapeutical approaches in cartilage disorders. Curr Gene Ther 2009; 9: 306–315.
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683–765.
van Roon J, Wijngaarden S, Lafeber FP, Damen C, van de Winkel J, Bijlsma JW . Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation. J Rheumatol 2003; 30: 648–651.
Schwager K, Kaspar M, Bootz F, Marcolongo R, Paresce E, Neri D et al. Preclinical characterization of DEKAVIL (F8-IL-10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis. Arthritis Res Ther 2009; 11: R142.
Kuroda T, Maruyama H, Shimotori M, Higuchi N, Kameda S, Tahara H et al. Effects of viral interleukin 1- introduced by in vivo electroporation on arthrogen-induced arthritis in mice. J Rheumatol 2006; 33: 455–462.
Khoury M, Bigey P, Louis-Plence P, Noel D, Rhinn H, Scherman D et al. A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis. J Gene Med 2006; 8: 1027–1036.
Apparailly F, Millet V, Noël D, Jacquet C, Sany J, Jorgensen C . Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 2002; 13: 1179–1188.
Perez N, Plence P, Millet V, Greuet D, Minot C, Noel D et al. Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther 2002; 13: 2161–2172.
Woods AM, Thompson SJ, Wolley PH, Panayi G, Klavinskis LS . Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis. Arthritis Rheum 2005; 52: 3761–3771.
Whalen JD, Lechman EL, Carlos CA, Weiss K, Kovesdi I, Glorioso JC et al. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 1999; 162: 3625–3632.
Quattrocchi E, Dallman MJ, Dhillon AP, Quaglia A, Bagnato G, Feldmann M . Murine IL-10 gene transfer inhibits established Collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J Immun 2001; 166: 5970–5978.
Gouze E, Pawliuk R, Pilapil C, Gouze JN, Fleet C, Palmer GD et al. In vivo gene delivery to synovium by lentiviral vectors. Mol Ther 2002; 5: 397–404.
Roybal JL, Santore MT, Flake AW . Stem cell and genetic therapies for the fetus. Semin Fetal Neonatal Med 2010; 15: 46–51.
Endo M, Henriques-Coelho T, Zoltick PW, Stitelman DH, Peranteau WH, Radu A et al. The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors. Gene Therapy 2010; 17: 61–71.
O’Garra A, Vieira P . T(H)1 cells control themselves by producing interleukin-10 (2007). Nat Rev Immunol 2007; 7: 425–428.
Gomez D, Correa PA, Gomez LM, Cadena J, Molina JF, Anaya JM . Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum 2004; 33: 404–413.
Gröndal G, Gunnarsson I, Rönnelid J, Rogberg S, Klareskog L, Lundberg I . Cytokine production serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000; 18: 565–570.
Ishida H, Muchamel T, Sakaguchi S, Andrade S, Menon S, Howard M . Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994; 179: 305–310.
Endo M, Zoltick PW, Peranteau WH, Radu A, Muvarak N, Ito M et al. Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter. Mol Ther 2008; 16: 131–137.
Endo M, Zoltick PW, Chung DC, Bennett J, Radu A, Muvarak N et al. Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Mol Ther 2007; 15: 579–587.
Bard JL, Kaufman MH, Dubreuil C, Brune RM, Burger A, Baldock RA et al. An internet-accessible database of mouse developmental anatomy based on a systematic nomenclature. Mech Dev 1998; 74: 111–120.
van de Loo FA, de Hooge AS, Smeets RL, Bakker AC, Bennink MB, Arntz OJ et al. An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint. Gene Therapy 2004; 11: 581–590.
Zhou G, Lefebvre V, Zhang Z, Eberspaecher H, de Crombrugghe B . Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 1998; 273: 14989–14997.
Angeles-Han S, Prahalad S . The genetics of juvenile idiopathic arthritis: what is new in 2010? Curr Rheumatol Rep 2010; 12: 87–93.
Mu J, Adamson SL . Developmental changes in hemodynamics of uterine artery, utero- and umbilicoplacental, and vitelline circulations in mouse throughout gestation. Am J Physiol Heart Circ Physiol 2006; 291: H1421–H1428.
Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, Zoltick PW et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 2008; 128: 1852–1860.
Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263–267.
Donello JE, Loeb JE, Hope TJ . Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 1998; 72: 5085–5092.
Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM . Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150–8157.
Zennou V, Serguera C, Sarkis C, Colin P, Perret E, Mallet J et al. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol 2001; 19: 446–450.
Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW . Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 2004; 122: 131–139.
Brand DD, Latham KA, Rosloniec EF . Collagen-induced arthritis. Nat Protoc 2007; 2: 1269–1275.
Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C . Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998; 160: 5213–5220.
Acknowledgements
JLR was supported by T32 HD046402 from the National Institutes of Health. AWF is also supported by funds from the Ruth and Tristram C Colket, Jr Chair of Pediatric Surgery. We would like to thank Carlyn Todorow and Catherine Tsai for help with subjective joint scoring, Archana Bora for help with qPCR and Marcus Davey for help with statistical calculations.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Gene Therapy website
Rights and permissions
About this article
Cite this article
Roybal, J., Endo, M., Radu, A. et al. Early gestational gene transfer of IL-10 by systemic administration of lentiviral vector can prevent arthritis in a murine model. Gene Ther 18, 719–726 (2011). https://doi.org/10.1038/gt.2011.23
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2011.23